Keyword: Propeller Health
At JPM, Propeller Health closed its $225 million buyout with ResMed and launched a partnership with Walgreens for in-app prescription refills.
Sanofi and Sema4 launched a five-year study of nearly 1,200 asthma patients, incorporating digital tools to better understand the disease.
ResMed is acquiring Propeller Health in a $225 million deal to broaden the reach of its connected respiratory devices across all stages of COPD.
Digital health data from smart-inhaler maker Propeller Health found that certain clinical guidelines for assessing control of asthma may be outdated.
Propeller Health and Aptar Pharma partner up to digitize drug delivery and offer a platform for pharma companies to track and manage patient usage.
The initiative will provide certain UnitedHealth members with Dexcom’s CGM technology and personalized coaching to help manage their diabetes.
The move represents a big win for Propeller Health, which has a chance to provide its sensor-enabled inhaler and app to a large group of patients.
Propeller Health is launching an API, as well as a series of tools based on it, that provides information on local asthma conditions.
GlaxoSmithKline and Propeller Health are expanding their R&D partnership, inked in 2015, into a commercial one.
Propeller Health is teaming up with Novartis to develop a custom add-on sensor for the Big Pharma’s Breezhaler inhaler. The tie-up marks Propeller’s fifth pharma partnership and its third with a major respiratory disease player.